Pharma funds outperform broader markets

Mutual fund schemes that invest in pharma stocks were seen outperforming last week.
 
Reliance Pharma Fund was the best performing fund last week. The fund delivered 3.74 per cent returns during the week even as BSE Sensex has managed to inch up 0.24 per cent.
 
Pharma stocks in the past one year have taken a beating owing to pricing pressure from the US markets.
 
BSE Healthcare index, the benchmark index for the sector, was one of the top performing sectoral indices during the week. BSE Healthcare index was up by nearly 3.34 per cent during the week, thus outperforming the benchmark indices Sensex and Nifty. Nifty inched up 0.32 per cent during the week.
 
Reliance Pharma Fund has over a one year period generated negative 2.83 per cent returns. Over the past one month, the fund is down by 1.76 per cent.
 
Cadila Healthcare, Aurobindo Pharma, Abbott India, Sanofi India, Dr. Reddy’s Laboratory, Sun Pharma, Divi’s Lab, Lupin, Tyrocare Technologies Ltd and Cipla are the top holdings in the fund.
 
SBI Pharma Fund is the other fund that invests in pharma stocks that outperformed the broader markets. SBI Pharma fund was up by nearly 3.08 per cent last week, thus catching investors’ attention.